NSC |
Compound |
Enrichment |
Correlation |
NSC 754329 |
Null |
0.0342636096654276 |
0.28724325 |
NSC 755119 |
Null |
0.0342636096654276 |
0.39409483 |
NSC 758027 |
Null |
0.0342636096654276 |
0.34494598 |
NSC 763275 |
(E)-8-(4-chlorobenzylidene)-4-(4-chlorophenyl)-3,4,5,6,7,8-hexahydroquinazolin-2-amine |
0.0342636096654276 |
-0.0095863377 |
NSC 105014 |
Cladribine |
0.0385613993886001 |
0.24045921 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0385613993886001 |
0.26705223 |
NSC 126728 |
WLN: T B-18-56 C6 A 2BC D& AX CX EOV KOV QVO VO MU OU A&UTJ B1 GQH1 B&1 A-& BT3OX CHJ |
0.0385613993886001 |
0.49479035 |
NSC 144126 |
Null |
0.0385613993886001 |
0.060673029 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0385613993886001 |
0.30070534 |
NSC 294961 |
5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one |
0.0385613993886001 |
0.34385343 |